Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Peptide derived from anti-idiotypic single-chain antibody is a potent antifungal agent compared to its parent fungicide HM-1 killer toxin peptide.

Kabir ME, Karim N, Krishnaswamy S, Selvakumar D, Miyamoto M, Furuichi Y, Komiyama T.

Appl Microbiol Biotechnol. 2011 Dec;92(6):1151-60. doi: 10.1007/s00253-011-3412-2. Epub 2011 Jun 21.

PMID:
21691785
2.

An altered camelid-like single domain anti-idiotypic antibody fragment of HM-1 killer toxin: acts as an effective antifungal agent.

Kabir ME, Krishnaswamy S, Miyamoto M, Furuichi Y, Komiyama T.

Appl Microbiol Biotechnol. 2011 Apr;90(2):553-64. doi: 10.1007/s00253-011-3123-8. Epub 2011 Feb 9.

PMID:
21305279
3.

An improved phage-display panning method to produce an HM-1 killer toxin anti-idiotypic antibody.

Kabir ME, Krishnaswamy S, Miyamoto M, Furuichi Y, Komiyama T.

BMC Biotechnol. 2009 Dec 14;9:99. doi: 10.1186/1472-6750-9-99.

4.

Cloning antifungal single chain fragment variable antibodies by phage display and competitive panning elution.

Krishnaswamy S, Kabir ME, Miyamoto M, Furuichi Y, Komiyama T.

Anal Biochem. 2009 Dec 1;395(1):16-24. doi: 10.1016/j.ab.2009.08.003. Epub 2009 Aug 7.

PMID:
19665444
5.

Inhibition of fungal beta-1,3-glucan synthase and cell growth by HM-1 killer toxin single-chain anti-idiotypic antibodies.

Selvakumar D, Miyamoto M, Furuichi Y, Komiyama T.

Antimicrob Agents Chemother. 2006 Sep;50(9):3090-7.

6.

Inhibition of beta-1,3-glucan synthase and cell growth of Cryptococcus species by recombinant single-chain anti-idiotypic antibodies.

Selvakumar D, Miyamoto M, Furuichi Y, Komiyama T.

J Antibiot (Tokyo). 2006 Feb;59(2):73-9.

PMID:
16629406
7.

Isolation and characterization of recombinant single chain fragment variable anti-idiotypic antibody specific to Aspergillus fumigatus membrane protein.

Krishnaswamy S, Kabir ME, Rahman MM, Miyamoto M, Furuichi Y, Komiyama T.

J Immunol Methods. 2011 Mar 7;366(1-2):60-8. doi: 10.1016/j.jim.2011.01.006. Epub 2011 Jan 28.

PMID:
21277307
8.

Different buffer effects in selecting HM-1 killer toxin single-chain fragment variable anti-idiotypic antibodies.

Krishnaswamy S, Kabir ME, Miyamoto M, Furuichi Y, Komiyama T.

J Biochem. 2010 May;147(5):723-33. doi: 10.1093/jb/mvq006. Epub 2010 Jan 22.

PMID:
20097900
9.

Recombinant single-chain anti-idiotypic antibody: an effective fungal beta-1,3-glucan synthase inhibitor.

Selvakumar D, Karim N, Miyamoto M, Furuichi Y, Komiyama T.

Biol Pharm Bull. 2006 Sep;29(9):1848-53.

10.

New avenues for phage-display library to produce a Cryptococcus-specific anti-idiotypic antibody of HM-1 killer toxin.

Rahman MM, Kabir ME, Krishnaswamy S, Miyamoto M, Furuichi Y, Komiyama T.

J Mol Recognit. 2011 Jul-Aug;24(4):631-41. doi: 10.1002/jmr.1075.

PMID:
21584874
11.

In vitro activity of a monoclonal killer anti-idiotypic antibody and a synthetic killer peptide against oral isolates of Candida spp. differently susceptible to conventional antifungals.

Manfredi M, McCullough MJ, Conti S, Polonelli L, Vescovi P, Al-Karaawi ZM, Porter SR.

Oral Microbiol Immunol. 2005 Aug;20(4):226-32.

PMID:
15943767
12.

Therapeutic activity of an engineered synthetic killer antiidiotypic antibody fragment against experimental mucosal and systemic candidiasis.

Polonelli L, Magliani W, Conti S, Bracci L, Lozzi L, Neri P, Adriani D, De Bernardis F, Cassone A.

Infect Immun. 2003 Nov;71(11):6205-12.

13.

Therapeutic activity of an anti-idiotypic antibody-derived killer peptide against influenza A virus experimental infection.

Conti G, Magliani W, Conti S, Nencioni L, Sgarbanti R, Palamara AT, Polonelli L.

Antimicrob Agents Chemother. 2008 Dec;52(12):4331-7. doi: 10.1128/AAC.00506-08. Epub 2008 Sep 29.

14.

From yeast killer toxins to antibiobodies and beyond.

Magliani W, Conti S, Travassos LR, Polonelli L.

FEMS Microbiol Lett. 2008 Nov;288(1):1-8. doi: 10.1111/j.1574-6968.2008.01340.x. Review.

15.

Killer peptide: a novel paradigm of antimicrobial, antiviral and immunomodulatory auto-delivering drugs.

Magliani W, Conti S, Ciociola T, Giovati L, Zanello PP, Pertinhez T, Spisni A, Polonelli L.

Future Med Chem. 2011 Jul;3(9):1209-31. doi: 10.4155/fmc.11.71. Review.

PMID:
21806382
16.

Yeast killer toxin-like candidacidal Ab6 antibodies elicited through the manipulation of the idiotypic cascade.

Polonelli L, Beninati C, Teti G, Felici F, Ciociola T, Giovati L, Sperindè M, Lo Passo C, Pernice I, Domina M, Arigò M, Papasergi S, Mancuso G, Conti S, Magliani W.

PLoS One. 2014 Aug 27;9(8):e105727. doi: 10.1371/journal.pone.0105727. eCollection 2014.

17.

Engineered killer mimotopes: new synthetic peptides for antimicrobial therapy.

Magliani W, Conti S, Salati A, Arseni S, Ravanetti L, Frazzi R, Polonelli L.

Curr Med Chem. 2004 Jul;11(13):1793-800. Review.

PMID:
15279582
18.

From Pichia anomala killer toxin through killer antibodies to killer peptides for a comprehensive anti-infective strategy.

Polonelli L, Magliani W, Ciociola T, Giovati L, Conti S.

Antonie Van Leeuwenhoek. 2011 Jan;99(1):35-41. doi: 10.1007/s10482-010-9496-3. Epub 2010 Aug 18.

PMID:
20714805
19.

A synthetic peptide as a novel anticryptococcal agent.

Cenci E, Bistoni F, Mencacci A, Perito S, Magliani W, Conti S, Polonelli L, Vecchiarelli A.

Cell Microbiol. 2004 Oct;6(10):953-61.

PMID:
15339270
20.

Protective antifungal yeast killer toxin-like antibodies.

Magliani W, Conti S, Frazzi R, Ravanetti L, Maffei DL, Polonelli L.

Curr Mol Med. 2005 Jun;5(4):443-52. Review.

PMID:
15978000

Supplemental Content

Support Center